Financing channel feed – Endpoints News

Financing channel feed

Third Rock-backed Cedilla reels in $57.6M for small molecule programs to fight cancer

5 years ago

Canaan raises another $800M as it launches its next fund with an emphasis on biotech

5 years ago

Months after retiring from Genentech, Michael Varney brings his drug hunting eye to Frazier

5 years ago

A major new investor just arrived at the biotech party, as Evotec nets $295M from Mubadala and Novo

5 years ago

Out to pioneer gene editing in China, EdiGene bags $67M to begin clinical testing for β-thalassemia therapy, universal CAR-T

5 years ago

Bob Langer-backed spinout shoots for $75M-plus IPO while biotech SPACs continue to rule on Wall Street

5 years ago

Novartis vets get $35M to pluck one of the pharma giant’s abandoned drugs off the shelf and put it back into a clinical trial

5 years ago

What are the right ingredients for a blockbuster unicorn IPO? Norbert Bischofberger has some thoughts on that

5 years ago

Three more biotechs go public Friday as nothing seems able to slow down the 2020 train

5 years ago

Sensei Biotherapeutics rakes in $28.5M to give cancer immunotherapies a push

5 years ago

How hot is Hong Kong's biotech IPO market? Two biotechs just raised $800M total

5 years ago

J&J, Cigna back a vant’s quest to go deeper into the data and start connecting the dots

5 years ago

Not two weeks after closing a Series D round, Galecto files for $100M IPO

5 years ago

Medicxi splashes more funding into Janpix's STAT protein degrader program

5 years ago

Venrock takes the wrap off its first microbiome startup, armed with $50M, a CEO from 23andMe and two founders from Stanford

5 years ago

A2 Biotherapeutics nabs $71M-plus Series B for selective cell therapy pipeline

5 years ago

Talaris Therapeutics bags another $115M to curb immunosuppression in organ transplant patients

5 years ago

Laid off from ImmunoGen, an ex-Genzyme and Shire exec heads to an ARCH upstart

5 years ago

C4's Andrew Hirsch blows up IPO to $182M, while oncolytic virus upstart nabs $87M offering

5 years ago

Cormorant's Bihua Chen joins the SPAC game, looking to raise $100M for a company that matches 5 key criteria

5 years ago

Is the future of diabetes drugs in dual GIP and GLP-1 incretin receptor agonists? That's the $47M question for Carmot

5 years ago

After recruiting an AstraZeneca vet as CEO to head a new team and raising $139M cash, little Olema appears to be ready to launch … something

5 years ago

Bidding to be the go-to genomics and data partner for drug development, Sophia Genetics raises $100M

5 years ago

A second Carl Icahn protégé jumps in on SPAC spree, as Alex Denner guns for $175M

5 years ago

First page Previous page 89 90 919293 94 95 Next page Last page